BioSpace News Archive

M*Modal Drives In-Workflow AI Innovation to Radically Transform Radiology Reporting and Empower Radiologists

M*Modal, a leading provider of clinical documentation and Speech Understanding solutions, today announced that it is further leveraging its advanced AI technology to deliver a smarter reporting workflow for radiologists and improved clinical outcomes for patients.

November 27, 2017

·

3 min read

Business

XTL Biopharma Reports Third Quarter 2017 Financial Results

XTL reported approximately $6,085 thousand in cash and cash equivalents as of September 30, 2017, an increase of $4,066 thousand since December 31, 2016.

November 27, 2017

·

12 min read

Drug Development

NYU Langone Health Release: Changes in Bacterial Mix Linked to Antibiotics Increase Risk for Inflammatory Bowel Disease

The study results center on the microbiome, the mix of bacterial species that live in our intestines and co-evolved with humans to play roles in digestion, metabolism, and immunity.

November 27, 2017

·

4 min read

Business

Philips Teams With 3D Printing Industry Leaders 3D Systems and Stratasys

Royal Philips today announced agreements with 3D Systems and Stratasys, two global leaders in the 3D printing industry, to help progress patient care and improve the clinician experience.

November 27, 2017

·

6 min read

FDA

Cochlear Obtains FDA Approval for First Remote Programming Option for Cochlear Implants

This approval is the first in the cochlear implant industry and one of many steps Cochlear is taking to enable remote care for Nucleus Cochlear Implant recipients and clinicians.

November 27, 2017

·

4 min read

Business

Stratasys Inks Deal to Bring Advanced 3D Printed Medical Modeling to Global Health Tech Leader Philips

The agreement includes virtually seamless interfacing and dedicated workflows across Philips IntelliSpace Portal 10 and Stratasys Direct Manufacturing’s parts-on-demand service.

November 27, 2017

·

5 min read

FDA

MorphoSys Announces That its Licensee Janssen Has Received Approval for Tremfya (Guselkumab) in Europe for the Treatment of Moderate-to-Severe Plaque Psoriasis

MorphoSys is eligible to receive royalties on net sales of Tremfya.

November 27, 2017

·

3 min read

Drug Development

European Commission Approves Tremfya (Guselkumab) for the Treatment of Moderate to Severe Plaque Psoriasis in the European Union

The EC approval is based on data from three Phase III clinical studies. The VOYAGE 1 and 2 trials, which compared guselkumab with placebo and HUMIRA.

November 27, 2017

·

9 min read

Business

TSO3 Announces the Death of Mr. Jean Lamarre

Mr. Lamarre contributed sound and constructive counsel on TSO3’s Board of Directors, and while leading TSO3’s Human Resources Committee.

November 27, 2017

·

1 min read

Business

Inflection Biosciences and RCSI Enter Research Collaboration to Target Therapy-Resistant Breast Cancer

Inflection Biosciences and RCSI, today announced a research collaboration that aims to understand mechanisms of resistance to major breast cancer therapies and examine potential new treatments of Inflection Biosciences for patients with a cancer that does not respond effectively to existing therapies.

November 27, 2017

·

4 min read